Furthermore, detailed head and neck cancer CSC biomarkers and their transcription factors are reviewed as CD44, CD133, ALDH, cMET and Oct-4, Nanog, Sox2, respectively [123,124]. This evidence concerns the gene SOX2 and head and neck cancer.